CELA3B
gene geneOn this page
Also known as CBPP
Summary
CELA3B (chymotrypsin like elastase 3B, HGNC:15945) is a protein-coding gene on chromosome 1p36.12, encoding Chymotrypsin-like elastase family member 3B (P08861). Efficient protease with alanine specificity but only little elastolytic activity.
Elastases form a subfamily of serine proteases that hydrolyze many proteins in addition to elastin. Humans have six elastase genes which encode the structurally similar proteins elastase 1, 2, 2A, 2B, 3A, and 3B. Unlike other elastases, elastase 3B has little elastolytic activity. Like most of the human elastases, elastase 3B is secreted from the pancreas as a zymogen and, like other serine proteases such as trypsin, chymotrypsin and kallikrein, it has a digestive function in the intestine. Elastase 3B preferentially cleaves proteins after alanine residues. Elastase 3B may also function in the intestinal transport and metabolism of cholesterol. Both elastase 3A and elastase 3B have been referred to as protease E and as elastase 1, and excretion of this protein in fecal material is frequently used as a measure of pancreatic function in clinical assays.
Source: NCBI Gene 23436 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 63 total
- MANE Select transcript:
NM_007352
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15945 |
| Approved symbol | CELA3B |
| Name | chymotrypsin like elastase 3B |
| Location | 1p36.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CBPP |
| Ensembl gene | ENSG00000219073 |
| Ensembl biotype | protein_coding |
| OMIM | 618694 |
| Entrez | 23436 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 2 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000337107, ENST00000374666, ENST00000400277, ENST00000473526
RefSeq mRNA: 1 — MANE Select: NM_007352
NM_007352
CCDS: CCDS219
Canonical transcript exons
ENST00000337107 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000956426 | 21981038 | 21981172 |
| ENSE00000956429 | 21984189 | 21984331 |
| ENSE00001464211 | 21977022 | 21977082 |
| ENSE00001613142 | 21983694 | 21983830 |
| ENSE00001724987 | 21980824 | 21980921 |
| ENSE00001761732 | 21978369 | 21978454 |
| ENSE00001890098 | 21989262 | 21989354 |
| ENSE00003659503 | 21986531 | 21986683 |
Expression profiles
Bgee: expression breadth ubiquitous, 125 present calls, max score 99.93.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 30.5644 / max 52552.5631, expressed in 14 samples.
FANTOM5 promoters (15 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 1244 | 30.5644 | 14 |
| 1243 | 0.3149 | 3 |
| 1245 | 0.3107 | 4 |
| 1248 | 0.1702 | 4 |
| 1242 | 0.0903 | 3 |
| 1249 | 0.0890 | 4 |
| 1246 | 0.0660 | 3 |
| 1251 | 0.0563 | 3 |
| 1241 | 0.0444 | 3 |
| 1252 | 0.0421 | 2 |
Top tissues by expression
133 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 99.93 | gold quality |
| pancreas | UBERON:0001264 | 97.29 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.96 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.69 | silver quality |
| body of stomach | UBERON:0001161 | 78.57 | gold quality |
| fundus of stomach | UBERON:0001160 | 77.60 | gold quality |
| duodenum | UBERON:0002114 | 75.58 | gold quality |
| ectocervix | UBERON:0012249 | 73.84 | gold quality |
| stomach | UBERON:0000945 | 73.78 | gold quality |
| right coronary artery | UBERON:0001625 | 73.32 | gold quality |
| right lobe of liver | UBERON:0001114 | 71.17 | gold quality |
| placenta | UBERON:0001987 | 70.98 | gold quality |
| left uterine tube | UBERON:0001303 | 70.75 | gold quality |
| endocervix | UBERON:0000458 | 70.09 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 69.83 | gold quality |
| right adrenal gland | UBERON:0001233 | 68.57 | gold quality |
| right uterine tube | UBERON:0001302 | 67.95 | gold quality |
| uterine cervix | UBERON:0000002 | 67.83 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 67.52 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 67.39 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 67.27 | gold quality |
| thoracic aorta | UBERON:0001515 | 66.99 | gold quality |
| left adrenal gland | UBERON:0001234 | 66.89 | gold quality |
| ascending aorta | UBERON:0001496 | 66.85 | gold quality |
| transverse colon | UBERON:0001157 | 66.66 | gold quality |
| apex of heart | UBERON:0002098 | 65.98 | gold quality |
| lower esophagus | UBERON:0013473 | 65.38 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 65.26 | gold quality |
| body of uterus | UBERON:0009853 | 65.09 | gold quality |
| metanephros cortex | UBERON:0010533 | 64.91 | gold quality |
Single-cell (SCXA)
Detected in 7 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ENAD-27 | yes | 10856.99 |
| E-GEOD-81547 | yes | 31.34 |
| E-MTAB-5061 | yes | 18.91 |
| E-GEOD-111727 | no | 44.33 |
| E-HCAD-31 | no | 3.26 |
| E-GEOD-83139 | no | 3.11 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 20)
- As an independent variable, correlated with C-peptide and HBA1c levels in type 1 diabetes. (PMID:15277440)
- pancreatic elastase induced proinflammatory effects are mediated by TLR4 and NF-kappaB in human myeloid cells (PMID:15351720)
- Patients with type 1 diabetes and low fecal elastase 1 concentrations were succesfully treatted with pancretin. (PMID:17103488)
- Fecal fat excretion is increased in patients with type 2 diabetes with fecal elastase deficiency. (PMID:17989309)
- Neither low fecal elastase 1 nor raised fecal fat levels reliably indicate exocrine pancreatic insufficiency in type-1 diabetes. (PMID:18362841)
- Reduced fecal elastase 1 connected with lowered serum levels of vitamin D3 is associated with osteoporotic bone fractures. (PMID:18424365)
- Parathormone levels and Vitamin D metabolism in female patients with various grades of fecal ELA1 deficiency are reported. (PMID:19073396)
- Hypermethylation of ELA3B gene promoter were associated with pancreatic cancer. (PMID:20428826)
- FE-1 is a poor surrogate for diagnosing impaired fat absorption. (PMID:22094930)
- A low value of faecal elastase-1, indicating reduced exocrine pancrease secretion, is strongly correlated with a poor survival in advanced pancreatic cancer. (PMID:22749648)
- Recombinant type I pancreatic elastase improves unassisted arteriovenous fistula maturation in hemodialysis patients. (PMID:24684771)
- The results of the study suggest that the levels of apelin, TNF-alpha and elastase-1 are important diagnostic markers of CP in patients with type 2 diabetes mellitus. (PMID:26817104)
- this study demonstrated a strong association of diabetes with low pancreatic elastase levels in feces (PMID:27069032)
- Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2. (PMID:27358403)
- variants affecting amino-acid position 241 in CELA3A and CELA3B are not associated with chronic pancreatitis, indicating that changes in complex formation between proelastases and procarboxypeptidases do not alter pancreatitis risk. (PMID:27999401)
- The aim of this study was to examine the frequency of exocrine dysfunctions of the pancreas according to the level of fecal elastase-1 (FE-1) in patients with diabetes mellitus, type 1 and diabetes mellitus, type 2. (PMID:30106003)
- Elastase 3B mutation links to familial pancreatitis with diabetes and pancreatic adenocarcinoma. (PMID:31369399)
- The reversion variant (p.Arg90Leu) at the evolutionarily adaptive p.Arg90 site in CELA3B predisposes to chronic pancreatitis. (PMID:33565216)
- Utility of Fecal Elastase-1 to diagnose severe exocrine insufficiency in chronic pancreatitis: Real world experience. (PMID:36610873)
- Does the Complex of CELA3B Variants With Other Pancreatitis-Related Genes Affect Developing Childhood Pancreatitis? (PMID:37307306)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cela3b | ENSMUSG00000023433 |
| mus_musculus | Cela3a | ENSMUSG00000078520 |
| rattus_norvegicus | Cela3b | ENSRNOG00000021619 |
Paralogs (6): CELA1 (ENSG00000139610), CELA2A (ENSG00000142615), CELA3A (ENSG00000142789), PRTN3 (ENSG00000196415), ELANE (ENSG00000197561), CELA2B (ENSG00000215704)
Protein
Protein identifiers
Chymotrypsin-like elastase family member 3B — P08861 (reviewed: P08861)
Alternative names: Elastase IIIB, Elastase-3B, Protease E
All UniProt accessions (2): P08861, A0A0A0MSA6
UniProt curated annotations — full annotation on UniProt →
Function. Efficient protease with alanine specificity but only little elastolytic activity.
Tissue specificity. Pancreas. Not detectable in keratinocytes.
Similarity. Belongs to the peptidase S1 family. Elastase subfamily.
RefSeq proteins (1): NP_031378* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001254 | Trypsin_dom | Domain |
| IPR001314 | Peptidase_S1A | Family |
| IPR009003 | Peptidase_S1_PA | Homologous_superfamily |
| IPR018114 | TRYPSIN_HIS | Active_site |
| IPR033116 | TRYPSIN_SER | Active_site |
| IPR043504 | ||
| IPR050850 | Peptidase_S1_Elastase_sf | Family |
Pfam: PF00089
UniProt features (18 total): disulfide bond 5, sequence conflict 4, active site 3, signal peptide 1, propeptide 1, sequence variant 1, chain 1, domain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P08861-F1 | 91.13 | 0.85 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (3): 73 (charge relay system); 123 (charge relay system); 217 (charge relay system)
Disulfide bonds (5): 157–223, 188–204, 213–244, 58–74, 117–120
Glycosylation sites (1): 114
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-9925561 | Developmental Lineage of Pancreatic Acinar Cells |
| R-HSA-1266738 | Developmental Biology |
| R-HSA-9734767 | Developmental Cell Lineages |
MSigDB gene sets: 53 (showing top):
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN, MYOD_01, SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5, GATA1_04, TAL1BETAE47_01, SANSOM_APC_TARGETS, GOBP_PROTEOLYSIS, E2A_Q2, GOMF_PEPTIDASE_ACTIVITY, chr1p36, BIOCARTA_PEPI_PATHWAY, SERVITJA_LIVER_HNF1A_TARGETS_UP, GATA1_05, FOXN3_TARGET_GENES, ZNF436_TARGET_GENES
GO Biological Process (1): proteolysis (GO:0006508)
GO Molecular Function (4): serine-type endopeptidase activity (GO:0004252), peptidase activity (GO:0008233), serine-type peptidase activity (GO:0008236), hydrolase activity (GO:0016787)
GO Cellular Component (1): obsolete extracellular space (GO:0005615)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Developmental Cell Lineages of the Exocrine Pancreas | 1 |
| Developmental Biology | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein metabolic process | 1 |
| endopeptidase activity | 1 |
| serine-type peptidase activity | 1 |
| hydrolase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| peptidase activity | 1 |
| serine hydrolase activity | 1 |
| catalytic activity | 1 |
Protein interactions and networks
STRING
826 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CELA3B | SCT | P09683 | 644 |
| CELA3B | CPA1 | P15085 | 627 |
| CELA3B | SPINK1 | P00995 | 546 |
| CELA3B | CPA2 | P48052 | 542 |
| CELA3B | PNLIP | P16233 | 542 |
| CELA3B | PNLIPRP1 | P54315 | 507 |
| CELA3B | CPB1 | P15086 | 501 |
| CELA3B | ENPEP | Q07075 | 480 |
| CELA3B | CFTR | P13569 | 477 |
| CELA3B | SYCN | Q0VAF6 | 468 |
| CELA3B | INS | P01308 | 421 |
| CELA3B | PTF1A | Q7RTS3 | 399 |
| CELA3B | CEL | P19835 | 393 |
| CELA3B | GRN | P23781 | 385 |
| CELA3B | GCG | P01275 | 385 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CELA3B | BCAT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CELA3B | HBD | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (14): CELA3B (PCA), TIMP3 (Affinity Capture-MS), NME2 (Affinity Capture-MS), GRN (Affinity Capture-MS), UBR7 (Affinity Capture-MS), SERPINB1 (Affinity Capture-MS), BCAT2 (Affinity Capture-MS), ADAMTS1 (Affinity Capture-MS), CELA3A (Affinity Capture-MS), UBR2 (Affinity Capture-MS), GDF15 (Affinity Capture-MS), HSP90AA4P (Affinity Capture-MS), HBD (Affinity Capture-MS), CELA3B (Positive Genetic)
ESM2 similar proteins: A0A126GUP6, A0A1S4H5M5, A0A6J1W8N1, B5U2W0, F5HKX0, O19023, O46644, O97366, P00772, P00773, P00774, P05208, P05805, P06871, P06872, P07477, P07478, P08217, P08218, P08419, P08861, P09093, P13582, P16049, P21902, P47796, P55091, P80009, P80010, Q29461, Q2VG86, Q3SYP2, Q49QW1, Q5R1M5, Q7M3E1, Q7M4I3, Q7PEV7, Q7QBP4, Q867B0, Q8I6K0
Diamond homologs: A1KXI1, C0HKF7, C0HKF8, O19023, O60235, O97370, O97398, P00760, P00761, P00762, P00763, P00764, P00765, P00766, P00767, P00768, P00769, P00771, P00774, P03951, P03952, P04813, P04814, P05208, P05805, P06871, P06872, P07146, P07338, P07477, P07478, P08217, P08218, P08419, P08426, P08861, P08897, P09093, P12788, P15947
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
63 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 48 |
| Likely benign | 8 |
| Benign | 4 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1010 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:21978367:A:AG | acceptor_gain | 1.0000 |
| 1:21978368:G:GA | acceptor_gain | 1.0000 |
| 1:21978368:GCCT:G | acceptor_gain | 1.0000 |
| 1:21980814:G:A | acceptor_gain | 1.0000 |
| 1:21980922:G:GG | donor_gain | 1.0000 |
| 1:21981033:CGCA:C | acceptor_loss | 1.0000 |
| 1:21981035:CAG:C | acceptor_loss | 1.0000 |
| 1:21981036:A:AG | acceptor_gain | 1.0000 |
| 1:21981036:A:G | acceptor_loss | 1.0000 |
| 1:21981036:AG:A | acceptor_gain | 1.0000 |
| 1:21981037:G:GT | acceptor_gain | 1.0000 |
| 1:21981037:GG:G | acceptor_gain | 1.0000 |
| 1:21981037:GGA:G | acceptor_gain | 1.0000 |
| 1:21981037:GGAGC:G | acceptor_gain | 1.0000 |
| 1:21981169:GTGG:G | donor_gain | 1.0000 |
| 1:21981171:GG:G | donor_gain | 1.0000 |
| 1:21981172:GG:G | donor_gain | 1.0000 |
| 1:21981172:GGTG:G | donor_loss | 1.0000 |
| 1:21981173:G:C | donor_loss | 1.0000 |
| 1:21981173:G:GG | donor_gain | 1.0000 |
| 1:21981174:TGA:T | donor_loss | 1.0000 |
| 1:21981175:GAGT:G | donor_loss | 1.0000 |
| 1:21981176:AGTG:A | donor_loss | 1.0000 |
| 1:21981177:G:C | donor_loss | 1.0000 |
| 1:21983831:G:GG | donor_gain | 1.0000 |
| 1:21984184:T:A | acceptor_gain | 1.0000 |
| 1:21984184:TGCA:T | acceptor_loss | 1.0000 |
| 1:21984186:CA:C | acceptor_loss | 1.0000 |
| 1:21984187:A:AG | acceptor_gain | 1.0000 |
| 1:21984188:G:GA | acceptor_gain | 1.0000 |
AlphaMissense
1747 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:21983817:G:C | W162C | 1.000 |
| 1:21983817:G:T | W162C | 1.000 |
| 1:21983699:A:C | D123A | 0.999 |
| 1:21983699:A:T | D123V | 0.999 |
| 1:21984299:T:A | C204S | 0.999 |
| 1:21984300:G:C | C204S | 0.999 |
| 1:21984326:T:A | C213S | 0.999 |
| 1:21984327:G:C | C213S | 0.999 |
| 1:21986535:A:T | D216V | 0.999 |
| 1:21980867:G:A | C58Y | 0.998 |
| 1:21980915:G:A | C74Y | 0.998 |
| 1:21980916:C:G | C74W | 0.998 |
| 1:21983698:G:C | D123H | 0.998 |
| 1:21983699:A:G | D123G | 0.998 |
| 1:21983802:C:G | C157W | 0.998 |
| 1:21983815:T:A | W162R | 0.998 |
| 1:21983815:T:C | W162R | 0.998 |
| 1:21983818:G:T | G163C | 0.998 |
| 1:21984251:T:A | C188S | 0.998 |
| 1:21984252:G:C | C188S | 0.998 |
| 1:21984327:G:A | C213Y | 0.998 |
| 1:21986535:A:C | D216A | 0.998 |
| 1:21986541:G:T | G218V | 0.998 |
| 1:21986597:A:C | S237R | 0.998 |
| 1:21986599:C:A | S237R | 0.998 |
| 1:21986599:C:G | S237R | 0.998 |
| 1:21986618:T:A | C244S | 0.998 |
| 1:21986619:G:C | C244S | 0.998 |
| 1:21986645:T:C | F253L | 0.998 |
| 1:21986647:C:A | F253L | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000509788 (1:21977652 C>T), RS1000637248 (1:21982931 T>C), RS1000898902 (1:21996096 C>A), RS1000950544 (1:21995790 G>A), RS1001079154 (1:21987513 G>T), RS1001353295 (1:21981340 G>A,T), RS1001533503 (1:21987193 G>A), RS1001568076 (1:21992847 C>T), RS1001620607 (1:21992660 G>A), RS1001855907 (1:21975813 T>G), RS1002205922 (1:21985125 T>A,G), RS1002307005 (1:21981950 C>A,T), RS1002472601 (1:21998981 G>A), RS1002685986 (1:21996599 C>T), RS1002892608 (1:21975301 A>G)
Disease associations
OMIM: gene MIM:618694 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002394_127 | Monocyte percentage of white cells | 5.000000e-18 |
| GCST90002407_388 | White blood cell count | 1.000000e-12 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007989 | monocyte percentage of leukocytes |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
2 total (human), top 2 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.